Explore the risks of ondansetron-induced QT prolongation, including FDA dosing limits, comparisons with safer antiemetics like palonosetron, and clinical best practices for protecting high-risk patients.
Health Information (165)
Health & Nutrition (9)
Science & Technology (5)
Health & Wellness (3)
Health (1)
May 2026 (8)
April 2026 (11)
March 2026 (12)
February 2026 (12)
January 2026 (25)
December 2025 (30)
November 2025 (20)
October 2025 (28)
September 2025 (15)
August 2025 (6)
July 2025 (21)